Ledger.Open graph →
SEC Form D · filed August 30, 2021

PROVECTUS BIOPHARMACEUTICALS, INC

Offering
$5.0M
Sold
$200K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
KNOXVILLE, TN
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Webster Bailey · Knoxville, TNDirectorEd Pershing · Knoxville, TNDirectorHeather Raines · Knoxville, TNExecDominic Rodrigues · Knoxville, TNDirectorEric Wachter · Knoxville, TNExecJohn Lacey, Iii · Knoxville, TNDirectorBruce Horowitz · Knoxville, TNExec · DirectorWebster Bailey · Knoxville, TNDirectorEd Pershing · Knoxville, TNDirectorHeather Raines · Knoxville, TNExecDominic Rodrigues · Knoxville, TNDirectorEric Wachter · Knoxville, TNExecJohn Lacey, Iii · Knoxville, TNDirectorBruce Horowitz · Knoxville, TNExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗